RedHill Biopharma RDHL
NASDAQ RDHL
$0.69 +0.04 (+5.31%)
As of: Sep 9, 2026 · 3:59 PM EDT

RedHill Biopharma (RDHL) Gross Margin Growth (1y) (2017 - 2023)

Analysis

RedHill Biopharma (RDHL) Gross Margin Growth (1y) (2017 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 164.00
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 156.00
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -1,039.00
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 250.00
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 316.00
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -1,747.00
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -235.00
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 124.00
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 598.00
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 415.00
Mar 31, 2023 323.00
Dec 31, 2022 2,042.00
Sep 30, 2022 -1,114.00
Jun 30, 2022 22.00
Mar 31, 2022 181.00
Dec 31, 2021 -3,796.00
Sep 30, 2021 665.00
Jun 30, 2021 1,864.00
Mar 31, 2021 11,257.00
Dec 31, 2020 -7.00
Sep 30, 2020 -446.00
Jun 30, 2020 -4,070.00
Mar 31, 2020 -13,840.00
Dec 31, 2019 -659.00
Sep 30, 2019 -1,779.00
Jun 30, 2019 366.00
Mar 31, 2019 1,403.00
Dec 31, 2018 295.00
Sep 30, 2018 3,428.00